These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32585757)

  • 1. Consideration on the study for safety of human papillomavirus(es) vaccine in Japan.
    Masuda T; Ueda Y; Kimura T
    J Obstet Gynaecol Res; 2020 Aug; 46(8):1471-1472. PubMed ID: 32585757
    [No Abstract]   [Full Text] [Related]  

  • 2. Bivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population: High Vaccine-Type-Specific Effectiveness and Evidence of Cross-Protection.
    Kudo R; Yamaguchi M; Sekine M; Adachi S; Ueda Y; Miyagi E; Hara M; Hanley SJB; Enomoto T
    J Infect Dis; 2019 Jan; 219(3):382-390. PubMed ID: 30299519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ongoing inadequacy of quadrivalent HPV vaccine safety studies.
    Little DT; Ward HR
    BMJ Evid Based Med; 2020 Apr; 25(2):44-45. PubMed ID: 30617051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Human papillomavirus infection and vaccination].
    He ZH; Kou ZQ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jan; 52(1):106-112. PubMed ID: 29334719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CURRENT ISSUES OF THE PAPILLOMAVIRUS INFECTION PREVENTION (REVIEW)].
    Oniskova O; Yushchenko L; Tikholaz V; Oleynik V; Moiseenko A
    Georgian Med News; 2018 Jun; (279):33-41. PubMed ID: 30035719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A vaccine against papillomavirus infections and cancer].
    Lehtinen M; Apter D; Heikkilä R; Heino P; Idänpään-Heikkilä I; Rimpilä K; Malm C; Zilliacus R
    Duodecim; 2002; 118(13):1397-404. PubMed ID: 12239887
    [No Abstract]   [Full Text] [Related]  

  • 7. Human Papillomavirus Vaccination Expected to Reduce Human Papillomavirus-Associated Cancers and May Lessen Racial/Ethnic Disparities of Cancer Incidence.
    Cates JR
    J Adolesc Health; 2019 Dec; 65(6):709-710. PubMed ID: 31753292
    [No Abstract]   [Full Text] [Related]  

  • 8. A human papillomavirus vaccine.
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):65-6. PubMed ID: 16977280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines for human papillomavirus infection: a critical analysis.
    Nath AK; Thappa DM
    Indian J Dermatol Venereol Leprol; 2009; 75(3):245-53; quiz 254. PubMed ID: 19439876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mounting evidence of the efficacy of human papillomavirus vaccines.
    Euro Surveill; 2006 May; 11(5):E060511.3. PubMed ID: 16816461
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of human papillomavirus vaccination depends on effective vaccination strategy.
    Lehtinen M; Paavonen J
    Int J Cancer; 2009 Sep; 125(6):1490-1. PubMed ID: 19507251
    [No Abstract]   [Full Text] [Related]  

  • 12. Knowledge of cervical cancer and the HPV vaccine.
    Paniagua H
    Br J Nurs; 2006 Feb 9-22; 15(3):126-7. PubMed ID: 16493315
    [No Abstract]   [Full Text] [Related]  

  • 13. Human papillomavirus (HPV) vaccine safety concerning POTS, CRPS and related conditions.
    Blitshteyn S
    Clin Auton Res; 2020 Apr; 30(2):181-182. PubMed ID: 31832903
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment.
    Bogani G; Leone Roberti Maggiore U; Signorelli M; Martinelli F; Ditto A; Sabatucci I; Mosca L; Lorusso D; Raspagliesi F
    Crit Rev Oncol Hematol; 2018 Feb; 122():92-97. PubMed ID: 29458794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parental acceptance of the human papillomavirus vaccine.
    Olshen E; Woods ER; Austin SB; Luskin M; Bauchner H
    J Adolesc Health; 2005 Sep; 37(3):248-51. PubMed ID: 16109349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to: Human papillomavirus (HPV) vaccine safety concerning POTS, CRPS and related conditions.
    Barboi A; Gibbons CH; Bennaroch EE; Biaggioni I; Chapleau MW; Chelimsky G; Chelimsky T; Cheshire WP; Claydon VE; Freeman R; Goldstein DS; Joyner MJ; Kaufmann H; Low PA; Norcliffe-Kaufmann L; Robertson D; Shibao CA; Singer W; Snapper H; Vernino S; Raj SR;
    Clin Auton Res; 2020 Apr; 30(2):183-184. PubMed ID: 31802304
    [No Abstract]   [Full Text] [Related]  

  • 17. Human Papillomavirus (HPV) Prevalence in Male Adolescents 4 Years After HPV-16/18 Vaccination.
    Lehtinen T; Söderlund-Strand A; Petäjä T; Eriksson T; Jokiranta S; Natunen K; Dillner J; Lehtinen M
    J Infect Dis; 2017 Nov; 216(8):966-968. PubMed ID: 28968844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination for human papillomavirus, part 1: why we need it.
    Silverberg NB
    Cutis; 2007 Nov; 80(5):385-6. PubMed ID: 18189023
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventing human papillomavirus-related cancers: we are all in this together.
    Dilley S; Scarinci I; Kimberlin D; Straughn JM
    Am J Obstet Gynecol; 2017 Jun; 216(6):576.e1-576.e5. PubMed ID: 28235464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.
    Hirth J; McGrath CJ; Kuo YF; Rupp RE; Starkey JM; Berenson AB
    Vaccine; 2018 Nov; 36(50):7682-7688. PubMed ID: 30377066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.